The case for cloud in life sciences

McKinsey & Company

As cloud technology matures, life-sciences companies are generating new paths to business value beyond the cost efficiencies that cloud migrations typically target. Insights on Life Sciences Medical products Pharmaceuticals Cloud computing

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs.

LHS Expert Insights: ESG Issues for Life Science Innovators

LaVoie Health Science Blog

Interviews with our senior practice managers about issues of important to life science innovators. As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors.

Capgemini Applauded by Frost & Sullivan for Enabling Businesses in the Life Sciences Industry to Transform and Manage Their Processes with Its End-to-end Digital Transformation and Technology Services

Frost & Sullivan

January 11, 2022 – Frost & Sullivan analyzed global digital transformation services in the life sciences industry and, based on its findings, recognizes Capgemin i with the 2021 Global Company of the Year Award for digital transformation services within life sciences.

ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform

Frost & Sullivan

LifeSphere supports hundreds of global life sciences companies to accelerate development, maintain compliance, and streamline collaboration between cross-functional teams. Best Practice Awards Healthcare & Life Sciences Best Practices News Press Releases

A new operating model for pharma: How the pandemic has influenced priorities

McKinsey & Company

Insights on Life Sciences PharmaceuticalsThe COVID-19 pandemic has prompted pharma companies to rethink their organizational strategies. A survey of executives suggests where value might lie.

The UK biotech sector: The path to global leadership

McKinsey & Company

The United Kingdom is Europe’s leading biotech hub in breakthrough life-sciences start-ups. Insights on Life Sciences Pharmaceuticals Medical products United KingdomHow is this hub maturing relative to its global peers, and what lies ahead on the road to sustainable scale?

The rise of digital marketing in medtech

McKinsey & Company

Insights on Life Sciences Medical products Digital marketing AnalyticsDigital marketing offers medtech companies powerful ways to personalize engagement with healthcare professionals and respond to their changing needs.

Clinical supply chains: How to boost excellence and innovation

McKinsey & Company

Insights on Life Sciences Pharmaceuticals Supply chain managementClinical trials have increased in number and have become more complex, decentralized, and patient-centric. While this puts pressure on clinical drug supply, it also brings new opportunities.

Embedding ‘smart quality’ culture and capabilities in the organization

McKinsey & Company

Insights on Life Sciences Pharmaceuticals Leadership StrategyPharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities.

Getting strategic about new-product submissions in the pharma industry

McKinsey & Company

Insights on Life Sciences PharmaceuticalsBy rethinking the approach to regulatory submissions, pharma companies can reduce timelines and increase their chances of successful product approvals.

Integrated evidence generation: A paradigm shift in biopharma

McKinsey & Company

Insights on Life Sciences Medical products PharmaceuticalsBiopharma companies should consider a new, integrated approach to evidence-generation strategies to better demonstrate the value of therapies to all stakeholders.

The dawn of China biopharma innovation

McKinsey & Company

Insights on Life Sciences Pharmaceuticals Medical products ChinaChinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem spur significant value creation.

Four ways pharma companies can make their supply chains more resilient

McKinsey & Company

Insights on Life Sciences Pharmaceuticals Supply chain managementPharmaceutical supply chains have become global and complex. With more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.

Forward Thinking on the enduring power of engineering in a digitizing world with Hayaatun Sillem

McKinsey & Company

The first female CEO of the United Kingdom’s Royal Academy of Engineering reflects on the evolving role of engineering in a dematerializing world, its vital role in science and sustainability—and collaborating with a Formula One world champion. Insights on Life Sciences

Pfizer’s mix of science and grit alters the course of COVID-19

McKinsey & Company

Insights on Life Sciences Pharmaceuticals Public healthAngela Hwang, Pfizer’s head of biopharmaceuticals, talks about breaking new ground when the pressure is on—and how having a deep company heritage can help.

Pfizer’s mix of science and grit alters the course of its COVID-19 response

McKinsey & Company

Insights on Life Sciences Pharmaceuticals Public healthAngela Hwang, Pfizer’s head of biopharmaceuticals, talks about breaking new ground when the pressure is on—and how having a deep company heritage can help.

Moderna’s path to vaccine innovation: A talk with CEO Stéphane Bancel

McKinsey & Company

Moderna’s delivery of a COVID-19 vaccine comes on the heels of revolutionary science that may accelerate innovation across the industry well into the future. Insights on Life Sciences Pharmaceuticals Public health Health care services Managing in Uncertainty Innovation

Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery

Frost & Sullivan

It employs deep learning algorithms, and different data science and data knowledge types to generate meaningful real-world evidence (RWE), helping to build a holistic view of the patient journey. Best Practice Awards Healthcare & Life Sciences Best Practices News Press Releases

Accelerating pandemic response efforts: An interview with CEPI’s Richard Hatchett

McKinsey & Company

Insights on Life Sciences Pharmaceuticals Public health LeadershipAmid the COVID-19 crisis, the CEO of the Coalition for Epidemic Preparedness Innovations explains his five-year strategy that includes reducing vaccine timelines.

LigoLab Applauded by Frost & Sullivan for Transforming Diagnostic Laboratories with its All-in-One Integrated LIS & RCM Platform

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSAN ANTONIO, TX.

Presagen Lauded by Frost & Sullivan for Innovating a New Model of Healthcare, Enabling Access to Diverse Global Datasets through Its AI Platform

Frost & Sullivan

Presagen demonstrates the value of its platform and global network approach with its flagship Life Whisperer products. Life Whisperer is an AI solution that can non-invasively assess embryos to determine the likelihood of pregnancy and genetic abnormalities using microscope images.

Stericycle Communication Solutions Earns Frost & Sullivan’s 2021 Best Practices Customer Value Leadership Award in the North America Patient Engagement Industry

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSANTA CLARA, Calif.

Visiba Care Applauded by Frost & Sullivan for Providing an Innovative Virtual Care Platform that Enhances Online Healthcare Consultations

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSANTA CLARA, Calif.

Cedar Gate Technologies Applauded by Frost & Sullivan for Enabling Personalized Care Management and Value-based Care with Its Population Health Management (PHM) Solutions

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSAN ANTONIO, TX. November 11, 2021 – Recently, Frost & Sullivan evaluated the North American population health management market.

Cedar Gate Technologies Applauded by Frost & Sullivan for Enabling Personalized Care Management and Value-based Care with Its Population Health Management (PHM) Solutions

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSAN ANTONIO, TX. November 18, 2021 – Recently, Frost & Sullivan evaluated the North American population health management market.

Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press Releases

Onyx Acclaimed by Frost & Sullivan for Facilitating Health Data Interoperability with Its SAFHIR Platform

Frost & Sullivan

Healthcare & Life Sciences Best PracticesSANTA CLARA, Calif. — — Based on its recent analysis of the North American healthcare data interoperability market, Frost & Sullivan recognizes Onyx Health (Onyx) with the 2021 North America Enabling Technology Leadership Award.

Validic Empowers Physicians and Care Managers to Manage Personal Health Data at Scale

Frost & Sullivan

Founded in 2010, Validic improves the quality of human life by building technology that makes personal data actionable. Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSANTA CLARA, Calif.

Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome

Frost & Sullivan

We provide services to help life sciences and biopharmaceutical customers everywhere transform scientific discoveries into new treatments. Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSANTA CLARA, Calif.

Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with Its Systems Integration Solution

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesBased on its recent analysis of the global market for operating room (OR) systems integration, Frost & Sullivan recognizes FUJIFILM Medical Systems USA, Inc.

Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press ReleasesSANTA CLARA, Calif.

From extreme to mainstream: The future of aesthetics injectables

McKinsey & Company

Insights on Life Sciences Medical products Consumer packaged goodsMcKinsey research shows that the global aesthetics injectables market could grow by 12 to 14 percent a year over the next five years if manufacturers and providers capitalize on the underlying trends.

Infographic: Biotech in Europe: Driving the next act

McKinsey & Company

Insights on Life Sciences BiotechnologyHow can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas.

Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™

Frost & Sullivan

is an international ingredients manufacturer whose primary goal is to provide health solutions that support optimal health for improved quality of life. In 2007, Kirin Holdings was established as a pure holding company and is currently focusing on boosting its Health Science domain.

Virtual Alliance Launch Best Practices

Vantage Partners

This past year, alliance launches across the life sciences industry shifted from in-person to completely virtual.

5G Networks to Unlock a New Era of Smartphone-based Point-of-care Testing Diagnostics

Frost & Sullivan

With smart connected solutions for healthcare providers, medical device manufacturers, and life sciences companies, 5G networks could unlock a new era of POCT diagnostics,” said Amartya Bose, Healthcare & Life Sciences Industry Analyst at Frost & Sullivan.

Reflections on 2020 ASAP BioPharma Conference: The right mindset is more important than ever

Vantage Partners

Overview The 2020 ASAP BioPharma conference came to a close a month ago and marked another year of bringing together talented and thoughtful strategic alliance professionals to share and reflect on their experiences in this field.

Frost & Sullivan Unfolds Top 5 Transformational Shifts Redefining the Healthcare Supply Chain

Frost & Sullivan

Global Lead, Supply Chain & Logistics; Siddharth Shah , Research Manager, Healthcare & Life Sciences; Unmesh Lal , Research Director, Healthcare & Life Sciences; and DHL’s Thomas Ellmann , Vice President, CSI Life Sciences & Healthcare, Head of Clinical Trials Logistics.